Filing Flows › Ironwood Pharmaceuticals (IRWD) › Q2 2025
Ironwood Pharmaceuticals (IRWD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 11, 2025
Ironwood Pharmaceuticals (IRWD) reported revenue of $85.2M for the second quarter 2025 (Q2 2025), -10% from a year earlier and +107% from the quarter before. Operating margin was 53.2%, net earnings $23.6M (27.7% of revenue).
Ironwood Pharmaceuticals, Q2 2025: revenue $85.2M (-10% year over year), operating margin 53.2%, net earnings $23.6M, operating cash flow −$15.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $85.2M | +107% | -10% |
| Operating profit | $45.3M | — | +81% |
| Net earnings | $23.6M | — | — |
| Operating cash flow | −$15.1M | -176% | — |
What changed
Revenue was $85.2M in Q2 2025, down 10% year over year and up 107% from the previous quarter.
Operating profit was $45.3M, a 53.2% margin (up 26.7 points year over year). Total costs fell 42% while revenue fell 10%. Net earnings were $23.6M. The effective tax rate was 37.6%.
Operating cash flow was −$15.1M. Non-cash charges added back $467K of depreciation and $4.5M of share-based compensation. Working capital and other items used $43.7M. Capital expenditures of $2K exceeded it, leaving free cash flow of −$15.1M.
Questions
What was Ironwood Pharmaceuticals' revenue in the second quarter 2025?
Ironwood Pharmaceuticals (IRWD) reported revenue of $85.2M for the second quarter 2025 (Q2 2025), -10% from a year earlier and +107% from the quarter before.
Was Ironwood Pharmaceuticals profitable in the second quarter 2025?
Operating profit was $45.3M (53.2% of revenue) and net earnings $23.6M.